Clinical decision-making in atypical and suspicious categories in fine-needle aspiration cytology of the breast

Marco Gipponi, Piero Fregatti, Alessandro Garlaschi, Massimo Calabrese, Paola Baccini, Maurizio Gallo, Federica Murelli, Cecilia M, [No Value] Argarino, Carolina Bobbio, Daniele Friedman

Research output: Contribution to journalArticle

Abstract

Backgroud: Fine-needle aspiration cytology (FNAC) is a simple and reliable technique to assess breast lesions, although a definitive differential diagnosis (benignity vs. cancer) is achieved approximately in 60-70% of cases because an inadequate (C1), atypical (C3) or suspicious (C4) category is otherwise reported. Patients and Methods: A retrospective analysis of 763 cases with C3 or C4 reports was performed to define their positive predictive value (PPV), as well as the practical implications of clinical and imaging findings as for clinical decision-making. FNACs were collected from January 2003 to September 2012 at the Breast Unit of IRCCS "A.O.U. San Martino-IST" Genoa, with each being received later to definitive histology. The PPV for cancer of C3/C4 categories were computed to measure the accuracy of FNAC; moreover, the PPV was also stratified according to clinical, mammography and sono graphy data alone or by their combination. Resuls: The PPV of C3 and C4 was 21.1% (80/380) and 84.1% (322/383), respectively. Within each C3/C4 category, a significant direct correlation (p

Original languageEnglish
Pages (from-to)2369-2374
Number of pages6
JournalAnticancer Research
Volume35
Issue number4
Publication statusPublished - Apr 1 2015

    Fingerprint

Keywords

  • Breast cancer
  • Breast imaging
  • Cytology

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Gipponi, M., Fregatti, P., Garlaschi, A., Calabrese, M., Baccini, P., Gallo, M., Murelli, F., M, C., Argarino, N. V., Bobbio, C., & Friedman, D. (2015). Clinical decision-making in atypical and suspicious categories in fine-needle aspiration cytology of the breast. Anticancer Research, 35(4), 2369-2374.